CD34 and breast carcinoma: The first one could affect early stages of DC differentiation and could be responsible for the increased frequency of CD34+ cells and decreased number of Lin-/HLA-DR+ DCs observed in the peripheral blood of breast cancer patients (Almand et al, 2000).